Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 60.48
+0.15 (0.25%)
At close: Feb 9, 2026
Apotea AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 7,205 | 6,541 | 5,450 | 4,883 | 4,580 |
Other Revenue | - | 5.6 | 5 | - | - |
| 7,205 | 6,547 | 5,455 | 4,883 | 4,580 | |
Revenue Growth (YoY) | 10.05% | 20.01% | 11.72% | 6.62% | 61.34% |
Cost of Revenue | 5,798 | 5,290 | 4,505 | 4,081 | 3,826 |
Gross Profit | 1,407 | 1,257 | 950.4 | 801.7 | 753.3 |
Selling, General & Admin | 956.1 | 875.8 | 744.2 | 712.1 | 601.6 |
Other Operating Expenses | -16.1 | -11.2 | -19.3 | -29.4 | -32.5 |
Operating Expenses | 1,102 | 994.2 | 837.6 | 752.7 | 618.9 |
Operating Income | 304.4 | 262.8 | 112.8 | 49 | 134.4 |
Interest Expense | -12 | -5.3 | -4.6 | -3.8 | -3.4 |
Interest & Investment Income | 3.6 | 4.2 | 1.5 | 0.2 | 0.2 |
Currency Exchange Gain (Loss) | - | 3 | -1.1 | -0.6 | -0.3 |
Other Non Operating Income (Expenses) | - | - | 0.1 | -0.1 | - |
EBT Excluding Unusual Items | 296 | 264.7 | 108.7 | 44.7 | 130.9 |
Gain (Loss) on Sale of Investments | -6.2 | - | - | -13.7 | - |
Pretax Income | 289.8 | 264.7 | 108.7 | 31 | 130.9 |
Income Tax Expense | 63.5 | 52.7 | 26.4 | 12.7 | 26 |
Earnings From Continuing Operations | 226.3 | 212 | 82.3 | 18.3 | 104.9 |
Net Income to Company | 226.3 | 212 | 82.3 | 18.3 | 104.9 |
Minority Interest in Earnings | 2.4 | 2.9 | 4.7 | 1.6 | - |
Net Income | 228.7 | 214.9 | 87 | 19.9 | 104.9 |
Net Income to Common | 228.7 | 214.9 | 87 | 19.9 | 104.9 |
Net Income Growth | 6.42% | 147.01% | 337.19% | -81.03% | 115.23% |
Shares Outstanding (Basic) | 104 | 103 | 102 | 102 | 102 |
Shares Outstanding (Diluted) | 104 | 103 | 102 | 102 | 102 |
Shares Change (YoY) | 1.52% | 0.62% | - | - | - |
EPS (Basic) | 2.20 | 2.10 | 0.85 | 0.20 | 1.03 |
EPS (Diluted) | 2.20 | 2.09 | 0.85 | 0.20 | 1.03 |
EPS Growth | 5.15% | 145.88% | 335.35% | -81.03% | - |
Free Cash Flow | 121.4 | 43.4 | 95.9 | -110.5 | 146.4 |
Free Cash Flow Per Share | 1.17 | 0.42 | 0.94 | -1.08 | 1.44 |
Dividend Per Share | 0.600 | - | - | - | - |
Gross Margin | 19.52% | 19.20% | 17.42% | 16.42% | 16.45% |
Operating Margin | 4.23% | 4.01% | 2.07% | 1.00% | 2.94% |
Profit Margin | 3.17% | 3.28% | 1.59% | 0.41% | 2.29% |
Free Cash Flow Margin | 1.69% | 0.66% | 1.76% | -2.26% | 3.20% |
EBITDA | 398.2 | 341.9 | 183.8 | 86.8 | 160.9 |
EBITDA Margin | 5.53% | 5.22% | 3.37% | 1.78% | 3.51% |
D&A For EBITDA | 93.8 | 79.1 | 71 | 37.8 | 26.5 |
EBIT | 304.4 | 262.8 | 112.8 | 49 | 134.4 |
EBIT Margin | 4.23% | 4.01% | 2.07% | 1.00% | 2.94% |
Effective Tax Rate | 21.91% | 19.91% | 24.29% | 40.97% | 19.86% |
Revenue as Reported | 7,224 | 6,562 | 5,478 | 4,913 | 4,612 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.